Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human vascular endothelial growth factor

EU orphan designation number: EU/3/09/711   
Active ingredient: Recombinant human vascular endothelial growth factor
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Newron Sweden AB
Fiskartorpsvagen 15 A-D, SE-114 33 Stockholm, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/02/2010 Centralised Orphan - Designation EMEA/OD/108/09 (2010)710 of 29/01/2010
27/03/2014 Centralised Orphan - Change of address